you are here: Home News Pharma Stocks

Pharma Stocks

Mutual funds stay loaded up on Indian pharma - even as Trump turns up the heat
Pharma stocks rebound as tariff fears ease; Sun Pharma, Lupin, Cipla lead gains
Trump torpedoes pharma sector with 100% tariff: How India's $50-billion industry could suffer and why US faces bigger risk
MC Exclusive: Investors must share blame for India Inc’s reluctance to sacrifice margins for growth, says Sunil Singhania
Pharma stocks fall up to 2% as Trump threatens steep tariffs on drug imports
Aurobindo Pharma, Dr Reddy's, Lupin, other pharma stocks tumble up to 3% amid tariff jitters
Auto, pharma stocks rally up to 6% amid US-India trade deal optimism
Pharma stocks sharply tumble as Donald Trump says 'pharma tariffs coming very soon'; Granules, Lupin, Laurus Labs fall up to 4%
Natco Pharma, Cipla, other pharma shares rise up to 4% as US to set targets to lower drugs prices, generics could be exempted
Indian generics likely insulated from Trump's drug pricing order, but Sun Pharma faces pressure
Defensives in demand: FMCG, pharma shares rally as market's gaining streak extends to six days
Pharma Q4 preview: Lupin, Sun Pharma, Cipla among top sectoral picks across brokerages
Pharma stocks rally on Trump's tariff pause, led by up to 7% surge in Laurus Labs, Granules, Cipla
Glenmark shares crash 6% after USFDA order discloses 39 drugs recalled from US market
Nifty Pharma extends losses for a fifth session as generics players fret over tariff deadline
Lupin, Zydus Life, other shares plunge up to 7%, as fears of Trump's pharma tariffs spook investors
Indian pharma firms dread tariffs, but US may have the worst side effects
Lupin, Dr Reddy's, other pharma stocks fall on Trump's 25% tariff plans
US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy's slump 2-4%
Pharma stocks suffer amid caution over Trump's tariff plans; Nifty Pharma index drops 2%
Weight loss drug opportunity is increasingly coming into focus for Indian pharma
Pharma stocks mixed after Sitharaman announces tax exemptions
Focus on new products at pharma companies as generic Revlimid opportunity draws to a close
Pharma stocks buck weak market; Dr Reddy's Labs, Cipla, Lupin up 1-4%
Lupin, Cipla, other pharma stocks fall up to 7% amid profit booking

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Pharma Stocks

Mutual funds stay loaded up on Indian pharma - even as Trump turns up the heat

Pharma stocks rebound as tariff fears ease; Sun Pharma, Lupin, Cipla lead gains

Trump torpedoes pharma sector with 100% tariff: How India's $50-billion industry could suffer and why US faces bigger risk

MC Exclusive: Investors must share blame for India Inc’s reluctance to sacrifice margins for growth, says Sunil Singhania

Pharma stocks fall up to 2% as Trump threatens steep tariffs on drug imports

Aurobindo Pharma, Dr Reddy's, Lupin, other pharma stocks tumble up to 3% amid tariff jitters

Auto, pharma stocks rally up to 6% amid US-India trade deal optimism

Pharma stocks sharply tumble as Donald Trump says 'pharma tariffs coming very soon'; Granules, Lupin, Laurus Labs fall up to 4%

Natco Pharma, Cipla, other pharma shares rise up to 4% as US to set targets to lower drugs prices, generics could be exempted

Indian generics likely insulated from Trump's drug pricing order, but Sun Pharma faces pressure

Defensives in demand: FMCG, pharma shares rally as market's gaining streak extends to six days

Pharma Q4 preview: Lupin, Sun Pharma, Cipla among top sectoral picks across brokerages

Pharma stocks rally on Trump's tariff pause, led by up to 7% surge in Laurus Labs, Granules, Cipla

Glenmark shares crash 6% after USFDA order discloses 39 drugs recalled from US market

Nifty Pharma extends losses for a fifth session as generics players fret over tariff deadline

Lupin, Zydus Life, other shares plunge up to 7%, as fears of Trump's pharma tariffs spook investors

Indian pharma firms dread tariffs, but US may have the worst side effects

Lupin, Dr Reddy's, other pharma stocks fall on Trump's 25% tariff plans

US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy's slump 2-4%

Pharma stocks suffer amid caution over Trump's tariff plans; Nifty Pharma index drops 2%

Weight loss drug opportunity is increasingly coming into focus for Indian pharma

Pharma stocks mixed after Sitharaman announces tax exemptions

Focus on new products at pharma companies as generic Revlimid opportunity draws to a close

Pharma stocks buck weak market; Dr Reddy's Labs, Cipla, Lupin up 1-4%

Lupin, Cipla, other pharma stocks fall up to 7% amid profit booking